Related Experiment Video
Updated: Apr 16, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Lung cancer screening: where have we been? Where are we going?
Abstract:
Recent evidence suggests that lung cancer screening with low-dose chest CT (LDCT) has a moderate net benefit on lung cancer mortality when applied to a high-risk population. This review article examines this evidence in light of the earlier failures of lung cancerscreening using chest radiography and/or sputum cytology. Harms associated with LDCT lung cancer screening include false positive results, false negative results, incidental findings, radiation exposure, and overdiagnosis. A number of issues related to implementation are unresolved.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Related Concept Videos
Cancer Prevention
Cancer Prevention
Some...
Cancer Survival Analysis
Longitudinal Research
Targeted Cancer Therapies
There are several types of targeted therapies against...
Statistical Methods for Analyzing Epidemiological Data